Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
37.28
-0.20 (-0.53%)
Jan 31, 2025, 4:00 PM EST - Market closed
Vera Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Vera Therapeutics stock have an average target of 68.86, with a low estimate of 38 and a high estimate of 107. The average target predicts an increase of 84.71% from the current stock price of 37.28.
Analyst Consensus: Buy
* Price targets were last updated on Nov 21, 2024.
Analyst Ratings
The average analyst rating for VERA stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 2 |
| Buy | 3 | 3 | 4 | 5 | 5 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 9 | 9 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $70 | Buy | Initiates | $70 | +87.77% | Nov 21, 2024 |
| Wedbush | Wedbush | Hold Maintains $30 → $38 | Hold | Maintains | $30 → $38 | +1.93% | Nov 8, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $72 → $75 | Buy | Maintains | $72 → $75 | +101.18% | Nov 5, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $56 → $64 | Strong Buy | Maintains | $56 → $64 | +71.67% | Oct 28, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $60 | Buy | Initiates | $60 | +60.94% | Oct 16, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.90
from -2.25
EPS Next Year
-3.23
from -2.90
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | 85.8M | |||
| Avg | n/a | n/a | 43.4M | |||
| Low | n/a | n/a | 7.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -2.54 | -2.33 | -2.38 | |||
| Avg | -2.90 | -3.23 | -3.06 | |||
| Low | -3.00 | -4.62 | -3.95 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.